Ramkumar Mandalam is Director at Cryoport, Inc. (CYRX). They have made 8 open-market trades across 1 company since 2020, most recently 2026-06-08.
CIK 0001611439
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CYRX | 67,894 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYRX | SELL | 2026-06-08 | 2026-06-08 | $15.44 | $358K | -2.9% | -1.2% | +0.1% |
| CYRX | SELL | 2025-12-10 | 2025-12-12 | $9.99 | $231K | +3.3% | +12.6% | -18.4% |
| CYRX | SELL | 2025-07-22 | 2025-07-24 | $7.24 | $590K | -15.5% | +10.4% | +26.6% |
| CYRX | SELL | 2025-06-24 | 2025-06-26 | $7.02 | $187K | +3.6% | +5.8% | +32.2% |
| CYRX | SELL | 2025-06-11 | 2025-06-13 | $7.05 | $133K | +9.5% | +12.6% | +42.2% |
| CYRX | SELL | 2025-06-09 | 2025-06-10 | $7.06 | $40K | -3.4% | +10.6% | +47.9% |
| CYRX | SELL · 10b5-1 | 2024-12-02 | 2024-12-04 | $7.46 | $110K | +3.3% | +13.7% | -32.3% |
| CYRX | SELL · 10b5-1 | 2024-08-02 | 2024-08-06 | $8.04 | $34K | +36.5% | +24.4% | +16.2% |
| CYRX | SELL | 2024-03-15 | 2024-03-19 | $14.68 | $47K | +11.3% | +1.1% | -39.9% |
| CYRX | SELL | 2020-11-24 | 2020-11-25 | $48.00 | $532K | +13.9% | -2.8% | +33.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.